Amedisys, Inc. (AMED)
NASDAQ: AMED · IEX Real-Time Price · USD
+0.17 (0.19%)
Jun 21, 2024, 4:00 PM EDT - Market closed

Amedisys Revenue

Amedisys had revenue of $2.25B in the twelve months ending March 31, 2024, with 0.76% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $571.41M with 2.70% year-over-year growth. In the year 2023, Amedisys had annual revenue of $2.24B with 0.59% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
3.00B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 20232.24B13.18M0.59%
Dec 31, 20222.22B9.09M0.41%
Dec 31, 20212.21B142.59M6.88%
Dec 31, 20202.07B115.89M5.93%
Dec 31, 20191.96B293.06M17.63%
Dec 31, 20181.66B151.31M10.01%
Dec 31, 20171.51B92.01M6.48%
Dec 31, 20161.42B138.72M10.83%
Dec 31, 20151.28B75.99M6.31%
Dec 31, 20141.20B-44.79M-3.59%
Dec 31, 20131.25B-191.49M-13.29%
Dec 31, 20121.44B22.37M1.58%
Dec 31, 20111.42B-182.61M-11.41%
Dec 31, 20101.60B116.69M7.86%
Dec 31, 20091.48B296.96M25.01%
Dec 31, 20081.19B489.48M70.13%
Dec 31, 2007697.93M156.79M28.97%
Dec 31, 2006541.15M159.59M41.83%
Dec 31, 2005381.56M154.47M68.02%
Dec 31, 2004227.09M84.62M59.39%
Dec 31, 2003142.47M13.05M10.08%
Dec 31, 2002129.42M19.25M17.47%
Dec 31, 2001110.17M22.02M24.98%
Dec 31, 200088.16M-9.26M-9.50%
Dec 31, 199997.41M71.95M282.51%
Dec 31, 199825.47M-344.00K-1.33%
Dec 31, 199725.81M-7.71M-23.01%
Dec 31, 199633.52M-4.07M-10.82%
Dec 31, 199537.59M8.69M30.06%
Dec 31, 199428.90M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Surgery Partners 2.79B
Envista Holdings 2.56B
ICU Medical 2.26B
LivaNova 1.19B
HUTCHMED (China) 838.00M
GoodRx Holdings 764.16M
Azenta 651.76M
Denali Therapeutics 295.39M
Revenue Rankings